MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202103_25197
Abstract: We detected some serious inaccuracies and mistakes. Therefore, the article "MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2, by M.-Z. Pan, Y.-L. Song, F. Gao, published in Eur Rev Med Pharmacol Sci 2019;… read more here.
Keywords: progression prostate; inhibits malignant; prostate cancer; mir 605 ... See more keywords
LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
Sign Up to like & getrecommendations! Published in 2022 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202205_28719
Abstract: The article "LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis, by T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao, published in Eur Rev Med Pharmacol Sci 2019; 23… read more here.
Keywords: progression prostate; prostate cancer; lncrna tug1; aggravates progression ... See more keywords
ANKRD22 is involved in the progression of prostate cancer
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Letters"
DOI: 10.3892/ol.2019.10738
Abstract: Prostate cancer is a common malignant tumor in elderly men. As a novel metabolic-reprogramming molecule, the role of ankyrin repeat domain 22 (ANKRD22) in the tumorigenesis and progression of prostate cancer remains unknown. In the… read more here.
Keywords: cancer; progression prostate; ankrd22; prostate cancer ... See more keywords